Vivos Sistema per Chirurgia Oftalmica di Olcayto Guelec and David Geuder

Il progetto Vivos Sistema per Chirurgia Oftalmica di Olcayto Guelec and David Geuder è un vincitore molto stimato del prestigioso 2026 A' Design Award d'Oro nella categoria Design di Dispositivi e Apparecchiature Mediche.

OroProdotto Medico· 2026

Vivos Sistema per Chirurgia Oftalmica

di Olcayto Guelec and David Geuder

Cliente: Geuder AG

Vincitore del premio A' Design Award d'Oro nella categoria Prodotto Medico

56,783

Vincitore del Premio Verificato

Verifica lo Stato del Premio per #182492

Vedi su A' Design Award Comunicato stampa Badge del premio

Colori

Il Design

Informazioni su Vivos Sistema per Chirurgia Oftalmica

Vivos ridefinisce la stazione di lavoro chirurgica come una piattaforma che si evolve di pari passo con l'ambizione clinica. Tre configurazioni, Core, Nova e Nova+, ampliano le capacità senza sostituire il sistema: l'unica architettura di aggiornamento nel suo genere nella chirurgia oftalmica. Un'unica interfaccia, validata con il 91,7 percento di soddisfazione al primo utilizzo senza formazione preliminare, riflette un design costruito attorno al chirurgo anziché alla procedura. Le connessioni degli strumenti illuminate, i materiali raffinati e i dettagli sobri conferiscono al dispositivo una presenza calma e sicura, libera dal rumore visivo tipico della categoria.

Il Riconoscimento

Informazioni sul A' Design Award d'Oro

Vivos Sistema per Chirurgia Oftalmica ha vinto l'A' Design Award d'Oro, un riconoscimento immensamente prestigioso conferito a design di primissima qualità, meravigliosi e straordinari. I vincitori d'Oro sono creazioni estremamente innovative, visionarie e di un fascino abbagliante che riflettono il genio, la saggezza e l'abilità dei loro designer. Ci si aspetta che Vivos Sistema per Chirurgia Oftalmica sia un'invenzione molto elogiata, all'avanguardia e monumentale che offre un valore senza precedenti. Questo design vincitore dell'A' Design Award d'Oro è un progetto spettacolare e rispettato che giova grandemente ai confini dell'arte, della scienza, del design e della tecnologia e li fa avanzare. Vivos Sistema per Chirurgia Oftalmica crea intensi sentimenti di desiderio, risveglia la passione, incoraggia la creatività e ci affascina.

Dietro il Design

Press Kit

Crediti, membri del team e dettagli tecnici forniti dal designer.

Proprietà Uniche: Vivos is the only ophthalmic surgery system that grows with clinical needs. Core for cataract. Nova adds vitrectomy. Plus adds laser. One platform. One interface. One training investment. Independent usability validation confirmed 92 percent user satisfaction among first time users. Illuminated connection sockets were rated positively by all study participants. Premium materials and restrained detailing give the device a likeable presence without the visual noise typical of the category.
Dimensioni e Confezionamento: Display: 24 inch capacitive touchscreen. Vitrectomy: up to 40000 cuts per min. Vacuum: up to 700 mmHg, highest in category. Phacoemulsification: 53 kHz piezoelectric. IOP: active real-time (VIVOS Balance). Endolaser: 532 nm. Illumination: SOLEA LED, 16.9M colours, 2 ports, Retina Protection Mode. CE pending, submitted Feb 2026. ISO 13485 2016.
Tag: Ophthalmic Surgery System, Medical Device Design, Phacoemulsification, Vitrectomy, Modular Medical Platform, Surgical Ergonomics, Workflow Design, German Medical Engineering, Usability Validation, Premium Medical Aesthetics
Tecnologia di Produzione: Medical-grade polycarbonate housing, antimicrobial surface coating rated for over 10,000 disinfection cycles. Piezoelectric phacoemulsification at 53 kHz with beveled-up probe geometry for optimised fluidics. Pneumatic vitrectomy probe up to 40,000 cuts/min. IEC 60601-1 compliant. Modular quick-change cassette - single or multi-patient - tool-free exchange. Compatible with older phaco handpieces, protecting prior investment. Individually assembled in Heidelberg. ISO 13485:2016, IEC 62366-1, IEC 60601-1, CE pending
Sfida Progettuale: The central challenge was integrating six surgical functions, historically distributed across two to three separate devices, into a single platform without increasing cognitive load. Internally, decades of segmented product architecture and a 75-year heritage required rethinking established engineering logic. Externally, MDR regulations, IEC 62366 1 usability standards and strict OR hygiene constraints limited design freedom. Maintaining identical UX across Core, Nova and Plus while ensuring durability for thousands of cleaning cycles demanded systemic redesign rather than incremental improvement.
Ricerca: Usability research was conducted. Objective: reduce cognitive load without limiting clinical capability. Methodology: iterative co-design workshops with surgeons, Geuder teams and engineering, followed by independent summative validation per IEC 62366-1. Data collection included usability testing and task-based evaluations. Participants: 13 first-time users at RWTH Aachen University, 2026. Results: 91.7% satisfaction, no unacceptable residual risks. Insights validated the workflow UI, surgeon profiles and illuminated sockets, contributing to greater efficiency, improved patient safety and long-term system adoption in clinical practice.
Ispirazione: Ophthalmic surgery is precise. Why should its devices remain fragmented, complex and visually uninspiring. Anterior and posterior procedures require separate investments, training and ecosystems not because clinical need requires it but because no manufacturer redesigned the architecture around the surgeon. Geuder AG with seventy five years of ophthalmic expertise asked what if one platform could grow without hardware replacement. Validated by independent study and unique in its modular upgrade logic.
Durata del Progetto: The project was developed in Heidelberg, Germany by Geuder AG. Development spanned multiple months with iterative design and engineering phases conducted in close collaboration with ophthalmic surgeons and operating room nursing staff. Summative usability validation was performed at RWTH Aachen University in early 2026. CE Mark application was submitted on 27 February 2026. Public market launch is scheduled for June 2026.
Flusso Operativo: Before each procedure, the surgeon selects a personal profile, preloading preferred settings and pedal sensitivity. A three-column touchscreen maps each surgical step as a visual sequence. Colour-coded modules allow instant identification in a darkened theatre. Illuminated sockets guide instrument connection by touch. The foot pedal, with individually adjustable actuation force, controls fluid flow and laser hands-free. Eye pressure is monitored and adjusted in real time.
Membri del Team: Collaboration between Geuder AG's Engineering, Quality Management, Regulatory Affairs, Product Management, Service, Application, Development, and Sales departments.
Crediti Immagini: Photography Geuder AG, 2026